Overexpression of aldose reductase in liver cancers may contribute to drug resistance

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Anti-Cancer Drugs

• Publication date

  2001-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00001813-200102000-00005PMID 11261885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osmotic Response Element Enhancer Activity

  1999cited by this paper
• Identification and Characterization of a Novel Human Aldose Reductase-like Gene*

  1998cited by this paper
• Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: Implication in detoxification of cytotoxic aldehydes

  1995cited by this paper
• Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate.

  1995cited by this paper
• Purification and properties of six aldo-keto reductases from rat adrenal gland.

  1994cited by this paper
• MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis.

  1993influential reference
• Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications.

  1992cited by this paper
• Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test.

  1991cited by this paper
• Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.

  1991cited by this paper
• Molecular mechanisms of drug resistance.

  1990cited by this paper
• Cloning and sequence determination of human placental aldose reductase gene.

  1989cited by this paper
• Molecular cloning of cDNA coding for kidney aldose reductase. Regulation of specific mRNA accumulation by NaCl-mediated osmotic stress.

  1989cited by this paper
• The involvement of aldose reductase in diabetic complications.

  1988cited by this paper
• Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.

  1987cited by this paper
• Purification and Characterization of Human‐Brain Aldose Reductase

  1982cited by this paper
• Purification and characterization of human-brain aldose reductase.

  1982cited by this paper
• Daunorubicin reduction mediated by aldehyde and ketone reductases.

  1981cited by this paper
• [The mechanism of the transformation of glucose in fructose in the seminal vesicles].

  1956cited by this paper
• Le mécanisme de la transformation de glucose en fructose par les vésicules séminales

  1956cited by this paper

• Methylglyoxal Formation—Metabolic Routes and Consequences

  2025cites this paper
• Enhancing ferroptosis and inhibiting ABCB1 make the novel aldose reductase inhibitor 5F-E a promising sensitizer in liver cancer

  2025cites this paper
• Hepatic aldose reductase drives a Warburg effect-like metabolic reprogramming to promote insulin resistance, fatty liver and obesity

  2024cites this paper
• mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.

  2023cites this paper
• Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis

  2023cites this paper
• Transcriptomic analysis of the fat body of resistant and susceptible silkworm strains, Bombyx mori (Lepidoptera), after oral treatment with fenpropathrin.

  2023cites this paper
• Plasma Insulin/Erythrocytic Aldose Reductase Ratio as a Predictor for Hepatocellular Carcinoma among Type II Diabetics and Hepatitis C Virus-infected Patients

  2022cites this paper
• Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease

  2022cites this paper
• Physiological and Pathological Roles of Aldose Reductase

  2021cites this paper
• Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.

  2021cites this paper
• Inhibition Profiles and Molecular Docking Studies of Anti-proliferative Agents Against Aldose Reductase Enzyme

  2021cites this paper
• Role of aldo‐keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential

  2020cites this paper
• Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues

  2020cites this paper
• Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases

  2019cites this paper
• Cooperative regulation of mouse aldose reductase (AKR1B3) gene transcription by Nrf2, TonEBP, and c-jun.

  2019cites this paper
• Novel Bouchardatine Analogs as Potential Inhibitors of Adipogenesis / Lipogenesis in 3 T 3L 1 adipocytes

  2018cites this paper
• Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma.

  2018cites this paper
• Design, synthesis and biological evaluation of novel bouchardatine analogs as potential inhibitors of adipogenesis/lipogenesis in 3T3-L1 adipocytes.

  2018cites this paper
• High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma

  2017cites this paper
• Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.

  2017cites this paper
• Phenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance

  2015influential citation
• Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.

  2015cites this paper
• High Expression of Aldo-Keto Reductase 1B10 Is an Independent Predictor of Favorable Prognosis in Patients with Hepatocellular Carcinoma

  2014cites this paper
• Preventive Cancer Stem Cell‐Based Vaccination Reduces Liver Metastasis Development in a Rat Colon Carcinoma Syngeneic Model

  2013cites this paper
• Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

  2012cites this paper
• Epidermal growth factor induces tumour marker AKR 1 B 10 expression through activator protein-1 signalling in hepatocellular carcinoma cells

  2012cites this paper
• Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors

  2012cites this paper
• Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.

  2011cites this paper
• Inhibition of Aldose Reductase Activates Hepatic Peroxisome Proliferator-Activated Receptor-α and Ameliorates Hepatosteatosis in Diabetic db/db Mice

  2011cites this paper
• Human aldo-keto reductases: structure, substrate specificity and roles in tumorigenesis

  2011cites this paper
• Diabetes and Nonalcoholic Fatty Liver Disease

  2011influential citation
• Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.

  2011cites this paper
• Aldo–Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers

  2011cites this paper
• Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds.

  2011cites this paper
• AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.

  2011cites this paper
• Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcription factor Nrf2.

  2011cites this paper
• Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway.

  2011cites this paper
• Targeting aldose reductase for the treatment of cancer.

  2011cites this paper
• [Downregulation of AKR1B10 gene expression in colorectal cancer].

  2010cites this paper
• Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10

  2010cites this paper
• Selectivity determinants of inhibitor binding to the tumour marker human aldose reductase-like protein (AKR1B10) discovered from molecular docking and database screening.

  2010cites this paper
• Downregulation of AKR1B10 expression in colorectal cancer

  2010cites this paper
• Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10.

  2010cites this paper
• Importance of influx and efflux systems and xenobiotic metabolizing enzymes in intratumoral disposition of anticancer agents.

  2009cites this paper
• Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.

  2009cites this paper
• Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.

  2009cites this paper
• The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells

  2009cites this paper
• Aldose reductase enzyme and its implication to major health problems of the 21(st) century.

  2009cites this paper
• Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels.

  2009cites this paper
• Aldo-keto Reductase Family 1 B10 Affects Fatty Acid Synthesis by Regulating the Stability of Acetyl-CoA Carboxylase-α in Breast Cancer Cells*

  2008cites this paper
• Decorin Transfection Induces Proteomic and Phenotypic Modulation in Breast Cancer Cells 8701-BC

  2008cites this paper
• Aldose Reductase Regulates Hepatic Peroxisome Proliferator-activated Receptor α Phosphorylation and Activity to Impact Lipid Homeostasis*

  2008cites this paper
• Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes.

  2007cites this paper
• Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression.

  2007cites this paper
• Aldo–keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention

  2007cites this paper
• PURIFICATION AND CHARACTERIZATION OF AKR1B10 FROM HUMAN LIVER: ROLE IN CARBONYL REDUCTION OF XENOBIOTICS

  2006cites this paper
• Expanding the protein catalogue in the proteome reference map of human breast cancer cells

  2006cites this paper
• Overexpression of aldose reductase in human cancer tissues.

  2006cites this paper
• Role of aldo-keto reductases in development of prostate and breast cancer.

  2006cites this paper
• Aldose reductase prevents aldehyde toxicity in cultured human lens epithelial cells.

  2006cites this paper
• Reversal of resistance to oxazaphosphorines.

  2006cites this paper
• Aldehyde Sources, Metabolism, Molecular Toxicity Mechanisms, and Possible Effects on Human Health

  2005cites this paper
• Modelling of aldose reductase inhibitory activity of pyrrol-1-yl-acetic acid derivatives by means of multivariate statistics.

  2005cites this paper
• Involvement of nuclear factor kappaB in up-regulation of aldose reductase gene expression by 12-O-tetradecanoylphorbol-13-acetate in HeLa cells.

  2005cites this paper
• Phorbol ester up-regulates aldose reductase expression in A549 cells: a potential role for aldose reductase in cell cycle modulation

  2005cites this paper
• Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene.

  2005cites this paper
• A differential proteomic approach to identify proteins associated with thyroid cell transformation.

  2005cites this paper
• Immunodetection of aldose reductase in normal and diseased human liver.

  2005cites this paper
• Medicament permettant de vaincre une resistance a des agents anticancereux et sa methode de criblage

  2004cites this paper
• The effect of new lipophilic chelators on the activities of cytosolic reductases and P450 cytochromes involved in the metabolism of anthracycline antibiotics: studies in vitro.

  2004cites this paper
• All in the family: aldose reductase and closely related aldo-keto reductases

  2004cites this paper
• Hepatitis C virus NS5A‐regulated gene expression and signaling revealed via microarray and comparative promoter analyses

  2004cites this paper
• Detection and identification of tumor‐associated protein variants in human hepatocellular carcinomas

  2004cites this paper
• [1-(3,5-difluoro-4-hydroxyphenyl)-1H-pyrrol-3-yl]phenylmethanone as a bioisostere of a carboxylic acid aldose reductase inhibitor.

  2004cites this paper
• Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines

  2003cites this paper
• A facile preparation of 1-(6-hydroxyindol-1-yl)-2,2-dimethylpropan-1-one.

  2003cites this paper
• Aldose reductase and the importance of experimental design.

  2003cites this paper
• Preparation and characterization of polyclonal antibodies against ARL-1 protein.

  2003cites this paper
• Pyrrolylbenzothiazole Derivatives as Aldose Reductase Inhibitors

  2002cites this paper
• Synthesis of [5-(4-pyrrol-1-yl-benzoyl)-1 H-pyrrol-2-yl)]-acetic acid and in vitro study of its inhibitory activity on aldose reductase enzyme and on protein glycation.

  2002cites this paper
• Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases

  2002cites this paper
• Aldose Reductase Inhibitors

  2001cites this paper
• TITLE : Mechanistic Basis for Use of Aldose Reductase Inhibitors to Treat Breast Cancer PRINCIPAL INVESTIGATOR :

  year unknowncites this paper